Patent · US Active

Type of cytidine derivative and application thereof

US10174067B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 9, 2015
Grant dateJan 8, 2019
Priority date
Expiry dateJun 9, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a new cytidine derivative having the general formula (I), and applications thereof:As demonstrated by experiments on the growth inhibition effect of the new cytidine derivative of the present invention on HCT-116 colon cancer xenografts in tumor-bearing nude mice, the compound of the present invention has high anti-tumor activity, data of impacts on weight of nude mice bearing human colon cancer HCT-116 and data of mortality rate showed that the toxicity of the compound is comparatively low.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.